What is Infusense?
Infusense is at the forefront of developing a novel biosensor platform engineered for precise drug quantification. Their technology achieves exceptional limits of detection, enabling rapid sample analysis within minutes. Employing an electrochemical modality, Infusense effectively miniaturizes laboratory-grade capabilities into a portable format, making advanced diagnostics more accessible. The company's solutions are primarily targeted at the healthcare and pharmaceutical sectors, addressing the critical need for accurate and efficient drug monitoring.
How much funding has Infusense raised?
Infusense has raised a total of $1.4M across 1 funding round:
Private Equity
$1.4M
Private Equity (2025): $1.4M, investors not publicly disclosed
What's next for Infusense?
The substantial enterprise-level backing positions Infusense for accelerated growth and market penetration. This significant capital injection is expected to fuel further research and development, scale manufacturing capabilities, and expand its commercial reach within the healthcare and pharmaceutical industries. The strategic nature of the recent investment suggests potential collaborations or synergistic opportunities that could enhance Infusense's market position and technological advancements in drug quantification.
See full Infusense company page
